Skip to Main Content
Division of Infectious Diseases

Research

Back to search

A Phase 3, Prospective, Multicenter, Double-Blind, Randomized, Controlled, Adaptive Study to Demonstrate the Safety and Efficacy of Defencath in Reducing Central Line-Associated Bloodstream Infections (CLABIs) in Adult Participants Receiving Total Parental Nutrition (TPN) via Central Venous Catheter (CVC) Compared with Heparin

Date:

07/01/2025

Topics:

Lead Investigators:

Summary

This is a Phase 3, randomized, double-blind, controlled, adaptive, 2-arm, multicenter study to demonstrate the efficacy and safety of DefenCath in adult participants receiving home Total Parenteral Nutrition (TPN) via Central Venous Catheter (CVC) compared with heparin.